Who invested in Clearside Biomedical

7 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$72Mraised across 7 rounds since 2012, from 7 sources

$4.0MVenture$7.9MVenture$6.0MVenture$16MSeries B$20MSeries C$15MRound$3.0MDebt

Latest round: Debt, $3.0MJul 2026
Biggest round: $20MSeries C · Dec 2015
Investors: 9

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122014201620182020202220242026

$4.0MVenture$7.9MVenture$6.0MVenture$16MSeries B$20MSeries C$15MRound$3.0MDebt

First round: Venture, $4.0M
Biggest round: $20M
Usual gap between rounds: 15 months

The rounds

Jul 2026
Debt$3.0M3 returning
Source recorded
Feb 2024
Round$15M3 returning
Source recorded
Dec 2015
Series C$20M4 new
From a historical funding recordSEC filing: $14M sold, first sale Nov 2015
Sept 2014
Series B$16M4 new1 returning
From a historical funding recordSEC filing: $16M sold, first sale Aug 2014
May 2014
Venture$6.0M
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Apr 2014
Feb 2013
Venture$7.9M
No investor was named in the report.
Reported by sec.govSEC filing: $7.9M sold, first sale Jan 2013
Jan 2012
Venture$4.0M1 new
- Hatteras Venture Partners
Reported by newsobserver.comSEC filing: $1.2M sold, first sale Jan 2012

Founders and team

From the SEC filings it signed: 2 on the team.

Charles A. DeignanExecutive Officeri
George LasezkayExecutive Officer, Directori

On the board, as filediChristy L. ShafferClay B. ThorpJeffrey L. EdwardsRichard D. CroarkinWilliam D. Humphries

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2012Venture2013Venture2014Series B2014Series C2015Round2024Debt2026

Hatteras Venture Partners

Perceptive Advisors

Cormorant Asset Management

Aju IB Investment

Mountain Group Partners

Rock Springs Capital

RMI LLCGeorgia Research AllianceSanten Pharmaceutical

Everyone who backed them

Hatteras Venture PartnersVC firm4rounds

Perceptive AdvisorsAsset manager3rounds

Cormorant Asset ManagementPrivate equity3rounds

Aju IB InvestmentVC firm1round

Mountain Group PartnersVC firm1round

Rock Springs CapitalHedge fund1round

RMI LLCGrowth equity1round

Georgia Research AllianceAngel1round

Santen PharmaceuticalCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Clearside Biomedical

Who invested in Clearside Biomedical?

Clearside Biomedical's investors include Hatteras Venture Partners, Perceptive Advisors, Cormorant Asset Management, Aju IB Investment and Mountain Group Partners, and 4 more on record.